This article is more than 5 years old. Information may no longer be current.

Iridex Q2 revenue up 15% from 2013

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Iridex reported revenues were $10.6 million in the second quarter of 2014, up 15% from $9.2 million in the second quarter of last year, according to a company press release.

The revenues for the first 6 months of 2014 were $20.9 million, up from 15% from $18.1 million in the first 6 months of last year, according to the release.

Gross margin also increased from 48.7% in the second quarter of last year to 50% this year.

Iridex reported an operating income of $0.4 million, compared with $0.5 million during the same period last year.

The company’s net income was $0.3 million, or $0.03 per diluted share, compared with the $0.4 million or $0.04 per diluted share net income in last year’s second quarter.

Iridex has reported it anticipates a revenue of $10 million to $10.3 million, and gross margin between 48% and 50%, with operating expenses expected at $4.6 million to $4.8 million, according to the release.